Aug 07, 2017 21:15 pm UTC| Business
IRVING, Texas, Aug. 07, 2017 -- Reata Pharmaceuticals, Inc. (NASDAQ:RETA) (“Reata” or the “Company”) today announced the enrollment of the first patient in the Phase 3 portion of the CARDINAL trial of bardoxolone methyl...
Aug 07, 2017 21:09 pm UTC| Business
NEW YORK, Aug. 07, 2017 -- Pensare Acquisition Corp. (NASDAQ:WRLSU) (the "Company") today announced that the holders of the Company’s units may elect to separately trade the common stock, warrants and rights underlying...
Eagle Bulk Shipping Inc. Reports Second Quarter 2017 Results
Aug 07, 2017 21:00 pm UTC| Business
STAMFORD, Conn., Aug. 07, 2017 -- Eagle Bulk Shipping Inc. (NASDAQ:EGLE) (the “Company” or “Eagle Bulk”), one of the world’s largest owner-operators in the Supramax / Ultramax segment, today reported financial results...
Idera Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Corporate Update
Aug 07, 2017 21:00 pm UTC| Business
CAMBRIDGE, Mass. and EXTON, Pa., Aug. 07, 2017 -- Idera Pharmaceuticals, Inc. (NASDAQ:IDRA), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel nucleic...
Willbros Announces Chief Financial Officer and Chief Accounting Officer Appointments
Aug 07, 2017 21:00 pm UTC| Business
HOUSTON, Aug. 07, 2017 -- Willbros Group, Inc. (NYSE:WG) announced today the promotion of Jeffrey B. Kappel and S. Brett Luz to key financial positions effective August 30, 2017. Mr. Kappel has been appointed Senior...
FreightCar America, Inc. Declares Regular Dividend
Aug 07, 2017 21:00 pm UTC| Business
CHICAGO, Aug. 07, 2017 -- The Board of Directors of FreightCar America, Inc. (NASDAQ:RAIL) has declared a regular cash dividend of $0.09 per share of common stock of the Company. The dividend is payable on August 23,...
Proteon Therapeutics Announces Second Quarter 2017 Financial Results
Aug 07, 2017 21:00 pm UTC| Business
WALTHAM, Mass., Aug. 07, 2017 -- Proteon Therapeutics, Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with kidney and vascular diseases, today...